Collard Craig A bought HRTX
January 19, 2024 · Form 4 insider transaction
Collard Craig A bought 220,750 shares of Heron Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
220,750
Price
$0.00
Total value
N/A
InsiderCollard Craig A
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateJanuary 19, 2024
Filing dateJanuary 19, 2024
Shares owned after220,750
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).